Badgley, Phelps & Bell’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Badgley, Phelps & Bell's AMGN Position: Q2 2021 in Review
Badgley, Phelps & Bell reduced its Amgen (AMGN) stake by 34% in Q2 2021, selling an estimated $5.06M and leaving 39,859 shares worth $9.72M. The position accounts for 0.36% of the portfolio, ranked #97.
Badgley, Phelps & Bell first reported a position in AMGN in Q4 2015 and has held it in 23 quarters since. The position peaked at $18.4M in Q4 2019. 2,195 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.
- Badgley, Phelps & Bell held 39,859 shares of Amgen worth $9.72M as of Q2 2021.
- Badgley, Phelps & Bell sold 20,575 Amgen shares in Q2 2021, an estimated $5.06M.
- Amgen made up 0.36% of Badgley, Phelps & Bell's portfolio in Q2 2021, its #97 holding.
- Badgley, Phelps & Bell first reported a position in Amgen in Q4 2015 and has held it in 23 quarters since.
- Badgley, Phelps & Bell's Amgen position peaked at $18.4M in Q4 2019.
- 2,195 funds tracked by Wall St. Rank held Amgen as of Q2 2021.
Based on Badgley, Phelps & Bell's 13F filing for Q2 2021, filed 28 Jul 2021.